49 related articles for article (PubMed ID: 9252684)
21. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
22. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
23. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
Chen F; Wang T; Wang J; Wang ZQ; Qian M
Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092
[TBL] [Abstract][Full Text] [Related]
24. Chinese herbs of Shenghe Powder reverse multidrug resistance of gastric carcinoma SGC-7901.
Wang J; Xia Y; Wang H; Hou Z
Integr Cancer Ther; 2007 Dec; 6(4):400-4. PubMed ID: 18048888
[TBL] [Abstract][Full Text] [Related]
25. A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity.
Karwatsky J; Lincoln MC; Georges E
Biochemistry; 2003 Oct; 42(42):12163-73. PubMed ID: 14567677
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines.
Maynadie M; Lizard G; Solary E; Roignot P; Carli PM
Anticancer Res; 1994; 14(6B):2605-9. PubMed ID: 7872688
[TBL] [Abstract][Full Text] [Related]
27. [Multidrug resistance of leukemia cells to cytostatics--the functional fluorescent dye efflux assay evaluated by flow cytometry].
Jankovicová K; Krejsek J; Kopecký O
Vnitr Lek; 2001 Jan; 47(1):25-9. PubMed ID: 15635865
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of multidrug resistant phenotype by flow cytometry with monoclonal antibodies and functional tests.
Lizard G; Maynadié M; Roignot P; Lizard-Nacol S; Poupon MF
Bull Cancer; 1995 Mar; 82(3):211-7. PubMed ID: 7655150
[TBL] [Abstract][Full Text] [Related]
29. Quantitative flow cytometric determination of anthracycline content of rat bone marrow cells.
Nooter K; van den Engh G; Sonneveld P
Cancer Res; 1983 Nov; 43(11):5126-30. PubMed ID: 6616450
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric monitoring of fluorescent drug retention and efflux.
Krishan A; Hamelik RM
Methods Mol Med; 2005; 111():149-66. PubMed ID: 15911978
[TBL] [Abstract][Full Text] [Related]
31. [Electron microscopy in the differential diagnosis of leukemias and lymphosarcomas].
Gogichadze GK
Vopr Onkol; 1980; 26(5):44-9. PubMed ID: 6892971
[TBL] [Abstract][Full Text] [Related]
32. A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia.
Redner A; Hegewisch S; Haimi J; Steinherz P; Jhanwar S; Andreeff M
Leuk Res; 1990; 14(9):771-7. PubMed ID: 2232849
[TBL] [Abstract][Full Text] [Related]
33. Functional multidrug resistance in acute myeloblastic leukaemia: a standardized flow cytometric assay for intracellular daunorubicin accumulation.
Pallis M; Russell NH
Br J Haematol; 1998 Jan; 100(1):194-7. PubMed ID: 9450811
[TBL] [Abstract][Full Text] [Related]
34. Active cell membrane mechanisms involved in the exclusion of Rh 123 allow distinction between normal and tumoral cells.
Lizard G; Chignol MC; Chardonnet Y; Schmitt D
Cell Biol Toxicol; 1994 Dec; 10(5-6):399-406. PubMed ID: 7697503
[TBL] [Abstract][Full Text] [Related]
35. P-glycoprotein mediated multidrug resistance assessment by flow-cytometry in malignant hemopathies.
Tatu CA; Paunescu V; Stanescu DI; Schneider F
Anticancer Res; 1997; 17(4A):2583-6. PubMed ID: 9252684
[TBL] [Abstract][Full Text] [Related]
36. Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance.
Frey T; Yue S; Haugland RP
Cytometry; 1995 Jul; 20(3):218-27. PubMed ID: 7587707
[TBL] [Abstract][Full Text] [Related]
37. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
38. The expression of multidrug resistance (MDR) molecule in acute leukemia and lymphoma.
Pituch-Noworolska A; Gawlicka M; Balwierz W
Pol J Pathol; 1995; 46(2):77-82. PubMed ID: 7640950
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance of acute leukemia and a strategy to overcome it.
Motoji T; Motomura S; Wang YH
Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
